Claremont Financial Group, Inc. Bristol Myers Squibb CO Transaction History
Claremont Financial Group, Inc.
- $23.4 Million
- Q1 2022
A detailed history of Claremont Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Claremont Financial Group, Inc. holds 1,500 shares of BMY stock, worth $73,050. This represents 0.5% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$73,050
Previous $116,000
-0.0%
% of portfolio
0.5%
Previous 0.5%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...